Antihemophilic Factor
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09109 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 29 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | pseudo-von Willebrand disease | KG + DL |
| 3 | Glanzmann thrombasthenia | KG + DL |
| 4 | Scott syndrome | KG + DL |
| 5 | acquired coagulation factor deficiency | KG + DL |
| 6 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 7 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 8 | flood factor deficiency | KG + DL |
| 9 | thrombotic thrombocytopenic purpura | KG + DL |
| 10 | hereditary thrombocytosis with transverse limb defect | KG + DL |
| 11 | familial thrombomodulin anomalies | KG + DL |
| 12 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 13 | inherited thrombophilia | KG + DL |
| 14 | platelet-type bleeding disorder | KG + DL |
| 15 | methylcobalamin deficiency type cblG | KG + DL |
| 16 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 17 | thrombocytopenic purpura | KG + DL |
| 18 | hemorrhagic disorder due to a platelet anomaly | KG + DL |
| 19 | hemophilia A with vascular abnormality | KG + DL |
| 20 | congenital factor V deficiency | KG + DL |
| 21 | congenital factor XIII deficiency | KG + DL |
| 22 | factor XIII, A subunit, deficiency | KG + DL |
| 23 | factor XI deficiency | KG + DL |
| 24 | inherited prekallikrein deficiency | KG + DL |
| 25 | congenital factor XI deficiency | KG + DL |
| 26 | Tatsumi factor deficiency | KG + DL |
| 27 | multiple sclerosis-ichthyosis-factor VIII deficiency syndrome | KG + DL |
| 28 | hemorrhagic disorder due to a coagulation factors defect | KG + DL |
| 29 | prothrombin deficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.